ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · Real-Time Price · USD
10.48
-0.01 (-0.10%)
At close: Oct 9, 2026, 4:00 PM EDT
10.57
+0.09 (0.85%)
After-hours: Oct 9, 2026, 7:30 PM EDT
ClearPoint Neuro Revenue
ClearPoint Neuro had revenue of $10.88M in the quarter ending June 30, 2026, with 18.07% growth. This brings the company's revenue in the last twelve months to $42.28M, up 25.86% year-over-year. In the year 2025, ClearPoint Neuro had annual revenue of $36.97M with 17.78% growth. That makes ClearPoint Neuro the 29,119th largest company in the world by revenue and 3,902nd in the United States.
Revenue (ttm)
$42.28M
Revenue Growth
+25.86%
P/S Ratio
7.56
Revenue / Employee
$245,808
Employees
172
Market Cap
319.68M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 36.97M | 5.58M | 17.78% |
| Dec 31, 2024 | 31.39M | 7.44M | 31.04% |
| Dec 31, 2023 | 23.96M | 3.40M | 16.56% |
| Dec 31, 2022 | 20.55M | 4.25M | 26.09% |
| Dec 31, 2021 | 16.30M | 3.47M | 27.05% |
| Dec 31, 2020 | 12.83M | 1.61M | 14.37% |
| Dec 31, 2019 | 11.22M | 3.86M | 52.54% |
| Dec 31, 2018 | 7.35M | -26.26K | -0.36% |
| Dec 31, 2017 | 7.38M | 1.63M | 28.35% |
| Dec 31, 2016 | 5.75M | 1.16M | 25.15% |
| Dec 31, 2015 | 4.59M | 989.71K | 27.46% |
| Dec 31, 2014 | 3.60M | -326.09K | -8.30% |
| Dec 31, 2013 | 3.93M | -1.13M | -22.29% |
| Dec 31, 2012 | 5.06M | 1.24M | 32.48% |
| Dec 31, 2011 | 3.82M | 1.15M | 43.03% |
| Dec 31, 2010 | 2.67M | 69.45K | 2.67% |
| Dec 31, 2009 | 2.60M | 650.00K | 33.33% |
| Dec 31, 2008 | 1.95M | 1.83M | 1,460.00% |
| Dec 31, 2007 | 125.00K | -842.83K | -87.08% |
| Dec 31, 2006 | 967.83K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Orthofix Medical | 833.19M |
| Viemed Healthcare | 301.61M |
| Treace Medical Concepts | 205.31M |
| InfuSystem Holdings | 143.34M |
| Standard BioTools | 84.60M |
| Shoulder Innovations | 60.06M |
| Mobia Medical | 45.28M |
| Profound Medical | 19.09M |
CLPT News
- 3 days ago - CLPT Investors with $100,000 in Losses Have Opportunity to Join ClearPoint Neuro, Inc. Fraud Investigation with SBS Law - Business Wire
- 2 months ago - ClearPoint Neuro price target lowered to $25 from $30 at Lake Street - TheFly
- 2 months ago - ClearPoint Neuro price target lowered to $22 from $25 at Stifel - TheFly
- 2 months ago - ClearPoint Neuro cuts FY26 revenue view to $48M-$52M from $52M-$56M - TheFly
- 2 months ago - ClearPoint Neuro reports Q2 EPS (38c), consensus (29c) - TheFly
- 2 months ago - ClearPoint Neuro Earnings Call Transcript: Q2 2026 - Transcripts
- 2 months ago - ClearPoint Neuro Earnings release: Q2 2026 - Filings
- 2 months ago - ClearPoint Neuro Slides: Q2 2026 - Filings